Jessica A. Hellings

3.2k total citations · 1 hit paper
47 papers, 2.1k citations indexed

About

Jessica A. Hellings is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Jessica A. Hellings has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cognitive Neuroscience, 28 papers in Psychiatry and Mental health and 19 papers in Clinical Psychology. Recurrent topics in Jessica A. Hellings's work include Autism Spectrum Disorder Research (33 papers), Attention Deficit Hyperactivity Disorder (22 papers) and Genetics and Neurodevelopmental Disorders (9 papers). Jessica A. Hellings is often cited by papers focused on Autism Spectrum Disorder Research (33 papers), Attention Deficit Hyperactivity Disorder (22 papers) and Genetics and Neurodevelopmental Disorders (9 papers). Jessica A. Hellings collaborates with scholars based in United States, Switzerland and France. Jessica A. Hellings's co-authors include Stephen R. Schroeder, Eric Prinssen, Laurie Chicha, Markus Britschgi, Stephen Toovey, Irène Knuesel, Michael Bodmer, Scott Schobel, Jennifer R. Zarcone and Gary Gaffney and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Jessica A. Hellings

46 papers receiving 2.0k citations

Hit Papers

Maternal immune activation and abnormal brain development... 2014 2026 2018 2022 2014 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica A. Hellings United States 22 1.1k 879 440 411 248 47 2.1k
Anne Masi Australia 12 1.1k 1.0× 501 0.6× 473 1.1× 395 1.0× 90 0.4× 34 1.7k
Rudimar dos Santos Riesgo Brazil 23 988 0.9× 462 0.5× 248 0.6× 443 1.1× 100 0.4× 80 1.7k
Cynthia A. Molloy United States 17 1.3k 1.3× 847 1.0× 403 0.9× 505 1.2× 184 0.7× 21 1.8k
Angela M. Reiersen United States 22 1.1k 1.0× 1.2k 1.4× 651 1.5× 349 0.8× 239 1.0× 46 2.4k
Miriam Cooper United Kingdom 11 847 0.8× 1.5k 1.7× 512 1.2× 289 0.7× 234 0.9× 17 2.2k
Patricia Manning‐Courtney United States 19 1.4k 1.3× 867 1.0× 603 1.4× 391 1.0× 129 0.5× 22 1.8k
Sanne Lemcke Denmark 12 546 0.5× 343 0.4× 241 0.5× 208 0.5× 53 0.2× 15 1.3k
Michael Chez United States 19 1.4k 1.3× 1.0k 1.2× 202 0.5× 788 1.9× 110 0.4× 41 2.4k
Josephine Elia United States 31 895 0.8× 2.1k 2.4× 1.1k 2.4× 178 0.4× 404 1.6× 59 3.0k
Olivier Bonnot France 25 550 0.5× 838 1.0× 329 0.7× 309 0.8× 63 0.3× 79 1.9k

Countries citing papers authored by Jessica A. Hellings

Since Specialization
Citations

This map shows the geographic impact of Jessica A. Hellings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica A. Hellings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica A. Hellings more than expected).

Fields of papers citing papers by Jessica A. Hellings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica A. Hellings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica A. Hellings. The network helps show where Jessica A. Hellings may publish in the future.

Co-authorship network of co-authors of Jessica A. Hellings

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica A. Hellings. A scholar is included among the top collaborators of Jessica A. Hellings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica A. Hellings. Jessica A. Hellings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hellings, Jessica A.. (2023). Pharmacotherapy in autism spectrum disorders, including promising older drugs warranting trials. World Journal of Psychiatry. 13(6). 262–277. 16 indexed citations
2.
Tumuluru, Rameshwari V., Michael G. Aman, Tristram Smith, et al.. (2017). Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism. Journal of Child and Adolescent Psychopharmacology. 27(8). 708–714. 14 indexed citations
3.
Smith, Tristram, Michael G. Aman, L. Eugene Arnold, et al.. (2016). Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study. Journal of the American Academy of Child & Adolescent Psychiatry. 55(10). 868–876.e2. 26 indexed citations
4.
Hellings, Jessica A., Gregory A. Reed, Sharon Cain, et al.. (2015). Loxapine Add-on for Adolescents and Adults with Autism Spectrum Disorders and Irritability. Journal of Child and Adolescent Psychopharmacology. 25(2). 150–159. 15 indexed citations
5.
Hellings, Jessica A., et al.. (2015). Low Dose Loxapine: Neuromotor Side Effects and Tolerability in Autism Spectrum Disorders. Journal of Child and Adolescent Psychopharmacology. 25(8). 618–624. 10 indexed citations
6.
Handen, Benjamin L., Michael G. Aman, L. Eugene Arnold, et al.. (2015). Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 54(11). 905–915. 94 indexed citations
7.
Aman, Michael G., Mallikarjuna Rettiganti, Haikady N. Nagaraja, et al.. (2015). Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 25(6). 482–493. 55 indexed citations
8.
Knuesel, Irène, Laurie Chicha, Markus Britschgi, et al.. (2014). Maternal immune activation and abnormal brain development across CNS disorders. Nature Reviews Neurology. 10(11). 643–660. 631 indexed citations breakdown →
9.
Cook‐Wiens, Galen, et al.. (2012). A Retrospective Study of Amitriptyline in Youth with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders. 43(5). 1017–1027. 8 indexed citations
10.
Youngs, Erin L., Rebecca S. Henkhaus, Jessica A. Hellings, & Merlin G. Butler. (2011). IL1RAPL1 gene deletion as a cause of X-linked intellectual disability and dysmorphic features. European Journal of Medical Genetics. 55(1). 32–36. 24 indexed citations
11.
Youngs, Erin L., Jessica A. Hellings, & Merlin G. Butler. (2011). ANKRD11 gene deletion in a 17-year-old male. Clinical Dysmorphology. 20(3). 170–171. 21 indexed citations
12.
Hellings, Jessica A., et al.. (2011). Long-Term Aripiprazole in Youth With Developmental Disabilities Including Autism. Journal of Mental Health Research in Intellectual Disabilities. 4(1). 40–52. 10 indexed citations
13.
Hellings, Jessica A., et al.. (2006). Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression in Children and Adolescents. Clinical Drug Investigation. 26(5). 247–255. 17 indexed citations
14.
Hellings, Jessica A., et al.. (2005). Risperidone-Induced Prolactin Elevation in a Prospective Study of Children, Adolescents, and Adults with Mental Retardation and Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 15(6). 885–892. 30 indexed citations
15.
Hellings, Jessica A., Elizabeth J. Nickel, Sharon Cain, et al.. (2005). ADouble-Blind, Placebo-Controlled Study of Valproate for Aggression in Youth with Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 15(4). 682–692. 116 indexed citations
16.
Zarcone, Jennifer R., Steven E. Lindauer, Kimberly Crosland, et al.. (2004). Effects of Risperidone on Destructive Behavior of Persons With Developmental Disabilities: III. Functional Analysis. American Journal on Mental Retardation. 109(4). 310–310. 42 indexed citations
17.
Valdovinos, Maria G., et al.. (2003). Using the Diagnostic Assessment of the Severely Handicapped‐II (DASH‐II) to measure the therapeutic effects of risperidone. Journal of Intellectual Disability Research. 48(1). 53–59. 6 indexed citations
18.
Hellings, Jessica A., et al.. (2002). Psychopathology, GABA, and the Rubinstein‐Taybi syndrome: A review and case study. American Journal of Medical Genetics. 114(2). 190–195. 24 indexed citations
19.
Sieg, Karl, Gary Gaffney, David F. Preston, & Jessica A. Hellings. (1995). SPECT Brain Imaging Abnormalities in Attention Deficit Hyperactivity Disorder. Clinical Nuclear Medicine. 20(1). 55–60. 124 indexed citations
20.
Gaffney, Gary, Karl Sieg, & Jessica A. Hellings. (1994). The MOVES: A Self-Rating Scale for Tourette's Syndrome. Journal of Child and Adolescent Psychopharmacology. 4(4). 269–280. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026